Happify Launches the First Prescription Digital Therapeutics to Treat Both MDD and GAD
Ensemble is the first transdiagnostic PDT for MDD and GAD available in the U.S. NEW YORK–(BUSINESS WIRE)–Happify Health, a global software-enabled healthcare platform, today announced the launch of Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD). Designed as […]